Medicine Overview of Triolmezest Tablet
Ankle swelling, Headache, Dizziness, Tiredness, Palpitations, Sleepiness, Increased blood uric acid, Glucose intolerance, Altered taste, Flushing (sense of warmth in the face, ears, neck and trunk), Stomach upset, Altered blood lipids.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Triolmezest 40 Tablet may be taken with or without food, but it is better to take it at a fixed time.
Triolmezest 40 Tablet is a combination of three medicines: Olmesartan, Amlodipine and Hydrochlorothiazide. Olmesartan is an angiotensin receptor blocker (ARB) and Amlodipine is a calcium channel blocker (CCB). They work by widening and relaxing the blood vessels, thereby lowering blood pressure. Hydrochlorothiazide is a diuretic which removes extra water and certain electrolytes from the body through urine. Over time it also works by relaxing blood vessels and improving blood flow.
In Depth Information on Triolmezest Tablet
Triolmezest Tablet related warnings
Taking Hydrochlorothiazide with alcohol may have additive effects in lowering blood pressure. You may experience headache, dizziness, lightheadedness, fainting, and/or changes in pulse or heart rate.
WEIGH RISKS VS BENEFITS
Triolmezest 40 Tablet is unsafe to use during pregnancy.
There is positive evidence of human fetal risk, but the benefits from use in pregnant women may be acceptable despite the risk, for example in life-threatening situations. Please consult your doctor.
Triolmezest 40 Tablet is probably safe to use during lactation.
Limited human data suggests that the drug does not represent a significant risk to the baby.
Do not drive unless you are feeling well.
Triolmezest 40 Tablet may cause side effects such as dizziness, headaches, nausea or tiredness, all of which could affect your ability to concentrate and drive.
Triolmezest 40 Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of Triolmezest 40 Tablet may be needed. Please consult your doctor.
Use of Triolmezest 40 Tablet is not recommended in patients with severe kidney disease.
Triolmezest 40 Tablet should be used with caution in patients with liver disease. Dose adjustment of Triolmezest 40 Tablet may be needed. Please consult your doctor.
No Patient Concerns found for this medicine
User Submitted Feedback For Triolmezest 40 Tablet
Patients taking Triolmezest 40 Tablet What were the side-effects while using Triolmezest 40 Tablet?
Increased blood uric acid
How do you take Triolmezest Tablet? How much was the improvement? Please rate Triolmezest 40 Tablet on price What are you using Triolmezest Tablet for?
Survey Participants: 35
“The following are the results of on-going survey on 1mg.com for Triolmezest 40 Tablet. These results only indicate the perceptions of the website users. Please base your medical decisions only on the advice of a doctor or a registered medical professional.”
One of the following vendor pharmacies will deliver Triolmezest 40 Tablet: RWP, RSS, BLE, KMC, ZVP, NTB, KIS, SGC, RHL, TFP, PRN, GPT, MLC, SYN, OLT, ARD, SWP, RDR, ANT, BLS, HNP, IAD, RUS, SBA, DHP, DFP, JHC, JVO, SWA, DVH, QTM, DGN, GNC, AAR, WSI, NVY, SJP, KHC, HAT, ENP, SDM, SVH, P2P, UBL, LHA, HSP, AAY, SMN, VNS, RPI, TNH, RPP, ATP, BDN, ZEL, OIP, RKS, AYM, VJS, WHL, NAS, AGT, UMP, MDO, INC, HGI, AMR, RHW, DYG, MDH, BTM, MAX, DAO, VDH, JIV, AVS, EMB, ZPR, SPD, SBL, PMA, NVL, BAP, 9T9, BHS, SVS, HMP, MAM, EPS, HBV, AWS, PNT, DPL, SCH, IPL, LCC, BHP, OHM, SGH, KHH, DZY, MSD, BHM, PTI, CHP, PLT, USF, NSL, LMS, HEX, GBL, SRG, PEN, QLF, HTS, VRS, JVN, SHD, NNH, DPP, NDP, MMS, JBT, PPR, NXG, GTC, NNP, RSA, STA, MAP, SSA, CLT, AYU, THP, SAF, TOM, GTK, SLN, EVP, RDH, SHC, ABP, BSN, ESY, BIO, HZF, EQN, HIP, FGH, MAK, PVP, RJH, HPC, OWP, BMJ, BAL, ADT, JSL, PWN, BBS, BGS, GHR, GPP, NWP, ATL, DHR, MPC, TRP